EMA creates advice portal for some high-risk medical devices
The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies.
GlobalData on MSN1d
EMA establish advisory portal for high-risk medical devices
The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.
Andalusia Star News1d
EMA officials track two potential storm threats
Two rounds of storms possible Wednesday, another Saturday night The Covington County Emergency Management Agency is keeping a ...
Medscape12d
EMA Recommends Approval of Capvaxive Pneumococcal Vaccine
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...
Daily1d
EMA establishes regular procedure for scientific advice on certain high-risk medical devices
European Medicines Agency (EMA), in close collaboration with the European Commission, has established a standard procedure ...
Medscape12d
EMA to Review New Safety Data on Alzheimer’s Drug Leqembi
The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.
Hosted on MSN11d
EMA recommends Bavarian Nordic’s chikungunya vaccine for adults and teenagers
If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.
NeuroTherapia Announces EMA Approval of its Phase 2 Trial for the Treatment of Alzheimer's Disease
NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, announced it has received approval for its Phase 2 clinical trial from the European ...
Ocugen’s OCU400 granted positive opinion by EMA in retinitis pigmentosa
Ocugen (OCGN) announced that the European Commission has provided a positive opinion from the EMA’s, or European Medicines Agency’s, Committee ...